Get Started

ENLV

NASD Enlivex Ltd.
Oct 29, 2026 · 8:07 AM ET LAST TRADE Market Closed

$2.50 ↓ -0.11 (-4.20%) Trading Down from the previous close of $2.61

YTD change
-98.52%
vs 20-day SMA
-37.12%
vs 200-day SMA
-98.23%

Price ranges

Previous day
$2.55 $2.77
open $2.71 close $2.61
-$0.10 (-3.69%)
Today
$0.00 $0.00
$2.50
Past week
$2.22 $3.28
from $3.24 now $2.50
-$0.73 (-22.72%)
Past month
$2.22 $8.04
from $8.04 now $2.50
-$5.54 (-68.92%)
This year
$0.16 $168.77
from $168.77 now $2.50
-$166.27 (-98.52%)

Price & Performance

+1.81 (+225.64%) / 6M

$-0.4163$2.38$5.18$7.98Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $10,776.00
  • ENLV is down 99% since the beginning of the year
  • ENLV is down 99% over the past 12 months
  • ENLV is down 69% over the past 1 month
  • 6% of all ENLV investors are betting against ENLV

ENLV reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +143.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-4.96
Earnings momentum -10.7% Quarterly EPS growth
Quarterly change -10.7%

Valuation

P/E ratio 0.00
Enterprise value $62.4M
Beta 2.87

Balance sheet & scale

Income$3.2M
RevenueN/A
Cash$5.6M
Debt$17.5K
Income / Debt 184.67×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.8M

Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.